![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024 Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ:...
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and...
Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 1,614,000 subscription rights...
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S. BCA's national network of blood centers...
Galapagos reports first quarter 2024 financial results Advanced potentially best-in-class cell therapy and small molecule R&D pipeline comprising four clinical assets and >15...
Mechelen, Belgium; 30 April 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announces that all resolutions proposed at the company’s Annual and Extraordinary Shareholders’...
Two oral presentations and one poster on encore preliminary data from Phase 1/2 CD19 CAR-T studies in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) / Richter transformation...
Publication of annual report for financial year 2023Annual Shareholders’ Meeting resolutions include approval of revised Remuneration Policy and (re)appointment of Board membersExtraordinary...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.62 | 2.62934690416 | 23.58 | 25.18 | 23.54 | 80820 | 24.60460523 | DE |
4 | 0.1 | 0.414937759336 | 24.1 | 25.18 | 23.02 | 68049 | 23.97615348 | DE |
12 | -3.38 | -12.2552574329 | 27.58 | 28.42 | 23.02 | 82028 | 25.3545046 | DE |
26 | -10.97 | -31.1913562695 | 35.17 | 37.17 | 23.02 | 81389 | 28.9722843 | DE |
52 | -12.95 | -34.8586810229 | 37.15 | 40.26 | 23.02 | 85014 | 32.25091249 | DE |
156 | -24.4 | -50.2057613169 | 48.6 | 66.28 | 23.02 | 197066 | 45.20141619 | DE |
260 | -127.6 | -84.0579710145 | 151.8 | 252.9 | 23.02 | 319062 | 102.19040192 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions